20.06.2013 Views

2006 ที่น้องแอนทำ.pmd - Mahidol University

2006 ที่น้องแอนทำ.pmd - Mahidol University

2006 ที่น้องแอนทำ.pmd - Mahidol University

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Mahidol</strong> <strong>University</strong> Abstract of International Publications <strong>2006</strong><br />

No.120<br />

Author(s) : Busaranon K, Suntornsuk W, Suntornsuk L.<br />

Title : Comparison of UV spectrophotometric method and high performance liquid<br />

chromatography for the analysis of flunarizine and its application for the dissolution<br />

test.<br />

Source : Journal of Pharmaceutical and Biomedical Analysis. 41 (1): 158 – 164, <strong>2006</strong> (Apr).<br />

Document Type : Article.<br />

Keywords : Flunarizine, UV spectrophotometric method, High performance liquid<br />

chromatography, Dissolution test.<br />

Abstract : This study aimed to develop a simple UV spectrophotometric method for the analysis<br />

and the dissolution test of flunarizine in capsules. The UV absorbance was both<br />

measured directly and by the first derivative measurements at 254 and 268 nm,<br />

respectively. The developed methods were validated for their linearity, accuracy,<br />

precision, limit of detection (LOD) and limit of quantitation (LOQ) in comparison with<br />

the reported HPLC method. The UV spectrophotometric method illustrated excellent<br />

linearity (r(2) > 0.9999) in the concentration range of 6 – 24 mu g/mL. Precision<br />

(%R.S.D. < 1.50) and recoveries were good (%R > 99.62). The LOD of direct UV and<br />

first derivative measurements were 0.09 and 0.84 mu g/mL, respectively, and the<br />

LOQ were 0.26 and 2.55 mu g/mL, respectively. Results from the assay of flunarizine<br />

in capsules by the UV spectrophotometric methods, both direct and first derivative<br />

measurements were not significantly different from those of the HPLC method (P ><br />

0.05). Additionally, the method was successfully used for the dissolution test of<br />

flunarizine capsule and was found to be reliable, simple, fast, and inexpensive.<br />

No.121<br />

Author(s) : Bussaratid V, Desakorn V, Krudsood S, Silachamroon U, Looareesuwan S.<br />

Title : Efficacy of ivermectin treatment of cutaneous gnathostomiasis evaluated by placebo<br />

– controlled trial.<br />

Source : Southeast Asian Journal of Tropical Medicine and Public Health. 37(3):433–440, <strong>2006</strong>.<br />

Document Type : Article.<br />

Keywords : –<br />

Abstract : Previous studies have revealed that ivermectin treatment for gnathostomiasis can<br />

reduce parasitic loads in animals and make recurrent subcutaneous swelling subside<br />

in 76% of patients. Our study aimed to evaluate the efficacy of ivermectin for<br />

cutaneous gnathostomiasis treatment in a placebo – controlled trial. This study was a<br />

prospective randomized placebo – controlled study performed at The Bangkok Hospital<br />

for Tropical Diseases, <strong>Mahidol</strong> <strong>University</strong>, Thailand. Thirty patients with a serologically<br />

confirmed diagnosis of cutaneous gnathostomiasis were enrolled. Seventeen patients<br />

in the ivermectin treated group received a single dose of 12 mg ivermectin (200 g/kg<br />

bodyweight), while 13 patients in the control group received a single dose of 40 mg of<br />

vitamin B1. The follow – up period was 1 year. Of the 17 patients, 7 (41.2%) responded<br />

to ivermectin, while no patient responded to placebo. The mean (95% CI) time to the<br />

first recurrence of subcutaneous swelling with ivermectin and in the placebo groups<br />

were 257 (184 – 331) and 146 (42 – 250) days, respectively, (p=0.102). Although this<br />

study revealed no significant difference in the mean time to first recurrence of<br />

swelling between the ivermectin and placebo groups, there was a trend towards<br />

ivermectin efficacy against gnathostomiasis in previous animal and human studies.<br />

Further studies with different doses of ivermectin and larger sample sizes, and close<br />

monitoring for ivermectin tolerability and treatment response are necessary to confirm<br />

an efficacy of ivermectin.<br />

No.122<br />

Author(s) : Butthep P, Chunhakan S, Tangnararatchakit K, Yoksan S, Pattanapanyasat K,<br />

Chuansumrit A.<br />

Title : Elevated soluble thrombomodulin in the febrile stage related to patients at risk for<br />

dengue shock syndrome.<br />

Source : Pediatric Infectious Disease Journal. 25 (10):894–897, <strong>2006</strong> (Oct).<br />

Document Type : Article.<br />

Keywords : Dengue hemorrhagic fever/dengue shock syndrome, Soluble thrombomodulin,<br />

Circulating endothelial cells.<br />

Abstract : Background: Children with dengue hemorrhagic fever (DHF) are at risk to develop<br />

dengue shock syndrome (DSS) for which neither marker has been demonstrated.<br />

Objective: The study was designed to investigate the markers of vascular endothelial<br />

cell injuries and dysfunction that might be used as early predictors of the subsequent<br />

manifestation of DSS. Methods: The blood samples from 111 patients with dengue<br />

42

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!